ASTRAZENECA AND MITSUBISHI TANABE PHARMA CORPORATION ANNOUNCE RESEARCH COLLABORATION IN DIABETIC NEPHROPATHY
AstraZeneca and Mitsubishi Tanabe Pharma Corporation (MTPC) today announce a three-year research collaboration in the area of diabetic nephropathy. The aim of the research collaboration is to leverage complementary strengths, expertise and assets to validate and progress novel research targets and molecules into clinical development.